Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hull

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Bulletin of the World Health Organization|October 5, 2001
The Australian Measles Control Campaign, 1998F M Turnbull, M A Burgess, P B McIntyre, et al.
Communicable Diseases Intelligence Quarterly Report|April 28, 2006
Australia's notifiable diseases status, 2004, annual report of the National Notifiable Diseases Surveillance SystemKeflemariam Yohannes, Paul W Roche, April Roberts, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Temporal and geographic patterns of hypoglycemia among hospitalized patients with diabetes mellitusRachel M Bailon, Curtiss B Cook, Michael J Hovan, et al.
International Journal of Retina and Vitreous|February 2, 2023
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degenerationJoseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|April 12, 2008
Balancing the role of the dental school in teaching, research and patient care; including care for underserved areasW P Holbrook, P Brodin, I Balciuniene, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 29, 2023
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF AgentsJoseph M Coney, Jasmyne E McCoy, Samriddhi Buxy Sinha, et al.
Journal of the American Academy of Dermatology|November 21, 1997
Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trialL A Drake, N H Shear, J P Arlette, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Bulletin of the World Health Organization|October 5, 2001
The Australian Measles Control Campaign, 1998F M Turnbull, M A Burgess, P B McIntyre, et al.
Communicable Diseases Intelligence Quarterly Report|April 28, 2006
Australia's notifiable diseases status, 2004, annual report of the National Notifiable Diseases Surveillance SystemKeflemariam Yohannes, Paul W Roche, April Roberts, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Temporal and geographic patterns of hypoglycemia among hospitalized patients with diabetes mellitusRachel M Bailon, Curtiss B Cook, Michael J Hovan, et al.
International Journal of Retina and Vitreous|February 2, 2023
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degenerationJoseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|April 12, 2008
Balancing the role of the dental school in teaching, research and patient care; including care for underserved areasW P Holbrook, P Brodin, I Balciuniene, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 29, 2023
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF AgentsJoseph M Coney, Jasmyne E McCoy, Samriddhi Buxy Sinha, et al.
Journal of the American Academy of Dermatology|November 21, 1997
Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trialL A Drake, N H Shear, J P Arlette, et al.
Pageof 14